2017-04-19 |
10 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,699,498 B1; . (Attachments…2019
20 July 2020
2:19-cv-00148
830 Patent
None
District Court, D. Vermont
|
External link to document |
2017-03-24 |
4 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,884,434 B1; 7,413,747 B2; 8,246,979…2019
20 July 2020
2:19-cv-00148
830 Patent
None
District Court, D. Vermont
|
External link to document |
2017-04-19 |
8 |
|
’979, ’980, and ’591 patents, and U.S. Patent No. 6,699,498
(“the ’498 patent”). Mylan denies the allegations…2, 2004, the USPTO issued U.S. Patent
No. 6,699,498 (“the ’498 patent”), entitled “Transdermal Therapeutic…of the ’434 Patent; the ’747 Patent;
the ’979 Patent; the ’980 Patent; and the ’591 Patent. This Court…27
(“the ’747 Patent”); 8,246,979 (“the ’979 Patent”); 8,246,980 (“the ’980 Patent”); and 8,617,591… 12. The ’498 patent, as well as U.S. Patent Nos. 6,884,434 (“the ’434 patent”),
7,413,747 (“the |
External link to document |
2019-08-26 |
92 |
Order Transferring Case |
209982), asserting U.S.
Patent Nos. 10,130,589 ("the '589 Patent") and 10,350,174 ("…infringement of United States Patent
Nos. 6,884,434 ("the ' 434 Patent"), 7,413 ,747 ("…quot;the ' 747 Patent"), 8,246,979 ("the ' 979 Patent"),
8,246,980 ("the …the '980 Patent"), and 8,617,591 ("the ' 591 Patent"), on May 24, 2017 (D.I. 1)…2019 (D.I. 82);
WHEREAS the ' 434 Patent was the subject of a recent decision from the United |
External link to document |